CIK 0001817713
- Large accelerated filer
Janux Therapeutics, Inc.
Sign in to watch- Ticker
- JANX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822289112
- Phone
- +1 858-751-4493
- Business address
- 10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO, CA, 92130
- FWP Offering Free Writing Prospectus
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- FWP Offering Free Writing Prospectus
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- CERT Other Certification
- 8-A12B Other Registration of Securities
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- D Other Notice of Sales of Unregistered Securities
- DRS Other Draft Registration Statement
Page 6 of 7 · 122 filings